| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/12/1999 | CA2153896C G-csf analog compositions and methods |
| 01/12/1999 | CA2138122C Pharmaceutical preparations for inhibiting tumours associated with prostate adenocarcinoma, stomach and breast cancer |
| 01/12/1999 | CA2117903C Targeted cleavage of rna using eukaryotic ribonuclease and external guide sequence |
| 01/12/1999 | CA2070503C A-c-b proinsulin, method of manufacturing and using same, and intermediates in insulin production |
| 01/12/1999 | CA1340312C Methods for improved targeting of antibody, antibody fragments, hormonesand other targeting agents and conjugates thereof |
| 01/10/1999 | CA2237138A1 25-hydroxyvitamin d3-1.alpha.-hydroxylase and dna encoding the hydroxylase |
| 01/10/1999 | CA2236493A1 Mura |
| 01/10/1999 | CA2236485A1 Novel 1spa |
| 01/09/1999 | CA2237158A1 Human semaphorin l (h-semal) and corresponding semaphorins in other species |
| 01/08/1999 | CA2236473A1 Novel pcra |
| 01/08/1999 | CA2236468A1 Novel use |
| 01/08/1999 | CA2229464A1 Hfizg53 |
| 01/07/1999 | WO1999000518A1 Member of the tnf family useful for treatment and diagnosis of disease |
| 01/07/1999 | WO1999000511A1 Targeted gene transfer using g protein coupled receptors |
| 01/07/1999 | WO1999000508A1 New human cathepsin |
| 01/07/1999 | WO1999000507A1 Phosphatidylinositol 4,5-bisphosphate 5-phosphatase from human |
| 01/07/1999 | WO1999000500A1 Calcium-binding phosphoprotein |
| 01/07/1999 | WO1999000499A1 Human fadd-interacting protein (fip) |
| 01/07/1999 | WO1999000498A1 Human nk-3 related prostate specific gene-1 |
| 01/07/1999 | WO1999000497A1 Proteins capable of binding to corticotropin-releasing factor |
| 01/07/1999 | WO1999000496A1 Novel osteoclast differentiation promoting factor and its gene |
| 01/07/1999 | WO1999000491A1 Novel plasmid dna containing reporter gene dna and use of the same |
| 01/07/1999 | WO1999000423A1 Protein that binds trail |
| 01/07/1999 | WO1999000422A1 Novel family of pheromone receptors |
| 01/07/1999 | WO1999000421A1 Site-directed chemotherapy of metastases |
| 01/07/1999 | WO1999000420A1 Kringle domains 1-5 of plasminogen, capable of modulating angiogenesis in vivo |
| 01/07/1999 | WO1999000418A1 Anti-inflammatory peptides derived from c-reactive protein |
| 01/07/1999 | WO1999000416A1 Use of heparin-binding protein for inhibiting entry of pathogens into mononuclear cells |
| 01/07/1999 | WO1999000415A1 Cardiotrophin-like cytokine |
| 01/07/1999 | WO1999000413A1 Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease |
| 01/07/1999 | WO1999000412A1 Interferon stimulating protein and uses thereof |
| 01/07/1999 | WO1999000411A2 Two new wd-40 proteins |
| 01/07/1999 | WO1999000410A2 Human extracellular matrix proteins |
| 01/07/1999 | WO1999000409A1 Chemically modified a-macroglobulins, methods of making, and methods of using the same in anti-cytokine therapy |
| 01/07/1999 | WO1999000408A2 Human transmembrane protein from the transmembrane 4 superfamily |
| 01/07/1999 | WO1999000406A1 CYCLIC AGONISTS AND ANTAGONISTS OF C5a RECEPTORS AND G PROTEIN-COUPLED RECEPTORS |
| 01/07/1999 | WO1999000405A1 Secreted proteins |
| 01/07/1999 | WO1999000404A1 Secreted proteins |
| 01/07/1999 | WO1999000403A1 Costal2 genes and their uses |
| 01/07/1999 | WO1999000383A1 Eprosartan monohydrate |
| 01/07/1999 | WO1999000361A1 Ace-inhibitor nitric salts |
| 01/07/1999 | WO1999000148A2 Method for treatment of spinal cord injuries in a mammal |
| 01/07/1999 | WO1999000147A1 Antigenomic oligodeoxynucleotides for treatment of infection by negative-stranded nonsegmented rna viruses |
| 01/07/1999 | WO1999000146A1 Development and use of human pancreatic cell lines |
| 01/07/1999 | WO1999000143A1 Cd154 blockade therapy for autoimmune diseases |
| 01/07/1999 | WO1999000141A1 Use of bromelain in the manufacture of a medicament for enhancement of intestinal permeability |
| 01/07/1999 | WO1999000140A2 Accelerating animal hoof growth with somatotropin |
| 01/07/1999 | WO1999000139A1 Antimicrobial agents from invertebrates |
| 01/07/1999 | WO1999000138A1 Methods and compounds for treating alzheimer's disease |
| 01/07/1999 | WO1999000137A2 Induction of an activated myeloid dendritic cell phenotype |
| 01/07/1999 | WO1999000136A1 Control of acidic gut syndrome |
| 01/07/1999 | WO1999000106A1 Intra-oral antioxidant preparations |
| 01/07/1999 | WO1999000022A1 Method for improving the efficacy of a probiotic, preparation of food additives and animal feed containing same |
| 01/07/1999 | WO1999000015A1 Method of enhancing magnesium absorption and prevention of atherosclerosis |
| 01/07/1999 | WO1999000002A2 Cyclosporin-containing microemulsion preconcentrate composition |
| 01/07/1999 | WO1998054213A3 Neurotrophic factor receptors |
| 01/07/1999 | WO1998045427A3 Insulin-like growth factor agonist peptides |
| 01/07/1999 | WO1998044893A3 Method and formulation for treating vascular disease |
| 01/07/1999 | WO1998044094A3 Helicobacter aliphatic amidase polypeptides, dna sequences encoding those polypeptides and uses thereof |
| 01/07/1999 | WO1998042824A3 Methods for selecting cells and their uses |
| 01/07/1999 | WO1998042740A3 Compounds and methods for the diagnosis and treatment of ehrlichia infection |
| 01/07/1999 | WO1998037100A3 Therapeutic use of the smr1 protein and active derivatives thereof |
| 01/07/1999 | WO1998035984A3 Compositions and methods for highly efficient transfection |
| 01/07/1999 | WO1998035048A3 Engineered protein kinases which can utilize modified nucleotide triphosphate substrates |
| 01/07/1999 | WO1998032853A3 Secreted proteins and polynucleotides encoding them |
| 01/07/1999 | WO1998028333A3 USPA1 AND USPA2 ANTIGENS OF $i(MORAXELLA CATARRHALIS) |
| 01/07/1999 | EP0889132A2 Streptococcus pneumoniae gidA2 polynucleotides and polypeptides |
| 01/07/1999 | EP0889131A2 Staphylococcus aureus gidA2 polynucleotides and polypeptides |
| 01/07/1999 | EP0889130A2 GidB polypeptides from Streptococcus pneumoniae |
| 01/07/1999 | EP0889129A2 GidA1 polypeptides from Staphylococcus aureus |
| 01/07/1999 | EP0889128A2 midA1 polypeptides from Streptococcus pneumoniae |
| 01/07/1999 | EP0889127A1 Serine/threonine protein kinase (H-SGK2) |
| 01/07/1999 | EP0889126A2 YNL075W/HTXFT19 polypeptide |
| 01/07/1999 | EP0889125A1 Monoclonal antibody 4G8b4b12 to human FLT3/FLK2 |
| 01/07/1999 | EP0889123A2 MurC gene of Staphylococcus aureus coding for UDP-N-acetylmuramate:L-alanine Ligase |
| 01/07/1999 | EP0889122A2 Inhibition of DNA Methyltransferase |
| 01/07/1999 | EP0889120A1 A micro-organism having reduced adaption to a particular environment |
| 01/07/1999 | EP0889054A2 Antibody 67D2 against CD164 |
| 01/07/1999 | EP0889053A2 Uses of BK-RiV preparations, process for their production and proteins comprised therein |
| 01/07/1999 | EP0889052A2 Immunoreactive peptides from Epstein-Barr virus |
| 01/07/1999 | EP0888543A1 Azatide peptidomimetics |
| 01/07/1999 | EP0888541A1 Cryptic peptides and method for their identification |
| 01/07/1999 | EP0888456A2 Prostate specific antigen oligo-epitope peptide |
| 01/07/1999 | EP0888453A1 Clostridium perfringens vaccines |
| 01/07/1999 | EP0888452A2 Extracellular matrix signalling molecules |
| 01/07/1999 | EP0888386A1 Stable factor viii/ von willebrand factor complex |
| 01/07/1999 | EP0888385A2 Uses of gdnf and gdnf receptor |
| 01/07/1999 | EP0888383A1 Anti-inflammatory peptides derived from c-reactive protein |
| 01/07/1999 | EP0888382A1 Chromatographic process for obtaining very pure cyclosporin a and related cyclosporins |
| 01/07/1999 | EP0888381A1 Targeted therapeutic or diagnostic agents and methods of making and using same |
| 01/07/1999 | EP0888377A1 MURINE $g(a)(1,3)FUCOSYLTRANSFERASE Fuc-TVII, DNA ENCODING THE SAME, METHOD FOR PREPARING THE SAME, ANTIBODIES RECOGNIZING THE SAME, IMMUNOASSAYS FOR DETECTING THE SAME, PLASMIDS CONTAINING SUCH DNA, AND CELLS CONTAINING SUCH A PLASMID |
| 01/07/1999 | EP0888375A1 A novel disintegrin metalloprotease and methods of use |
| 01/07/1999 | EP0888374A1 High affinity nucleic acid ligands of complement system proteins |
| 01/07/1999 | EP0888373A1 Smooth muscle cell lim protein |
| 01/07/1999 | EP0888370A1 Thyroid sodium/iodide symporter and nucleic acid encoding same |
| 01/07/1999 | EP0888138A1 Topical formulations for the treatment of nail psoriasis |
| 01/07/1999 | EP0888128A2 Delivery of exogenous compounds |
| 01/07/1999 | EP0888125A1 Glycosylated humanized b-cell specific antibodies |
| 01/07/1999 | EP0888123A2 Antagonism of endothelin actions |
| 01/07/1999 | EP0888122A1 HYBRID WITH INTERFERON-alpha AND AN IMMUNOGLOBULIN Fc LINKED THROUGH A NON-IMMUNOGENIC PEPTIDE |